Perspective · 10 Sep 2026
Conference abstractPublished 20 Jul 2015
The emerging role of innate chemokines in inflammatory disease and atherosclerosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Inflammatory processes such as those promoting atherosclerotic lesion formation are pivotely driven components of the innate and adaptive immune axis. Chemokines and their receptors are a particularly prominent part of the innate immune arm. While the role of classical chemokines, i.e. belonging to the CC or CXC families, is increasingly well understood, it also has become clear that the underlying ligand/receptor system is characterized by a previously unanticipated complexity of crossreactivities and homo- and heteromerization events. Moreover, an emerging family of chemokine-like inflammatory mediators termed â??innate chemokinesâ??, CLF chemokines or micro-chemokines, which additionally structurally and functionally overlaps with the mediator class of alarmins has been identified to modulate inflammatory reactions in the atherogenic arterial wall but also numerous other inflamed tissues. Innate or CLF chemokines share functional homology with classical chemokines and signal through classical chemokine receptors, whereas they do not exhibit conserved structural features such as N-terminal tandem cysteine residues or the chemokine fold. This lecture will address the molecular basis of target cell activity and the pathophysiological role of several â??innate chemokinesâ??. Examples will encompass high mobility group binding protein-1 (HMGB1), macrophage migration inhibitory factor (MIF), and certain β-defensins. Receptor usage, signaling, innate immune cell regulation, and involvement in various inflammatory conditions, including atherosclerosis will be discussed. Finally, the lecture will outline potential strategies to specifically and therapeutically target such mediators either in conjunction or explicit exclusion of the co-targeting of classical chemokines.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Jürgen Bernhagen”
